The McLaren Proton Therapy Center is poised to become the first in the world to deliver proton therapy to patients with Leo Cancer Care’s ground-breaking upright treatment technology. In a landmark agreement, Leo Cancer Care will install two upright units at the McLaren Proton Therapy Center in Flint, Michigan, with the first patients set to receive care via the innovative treatment delivery system within the next two years upon receipt of FDA’s clearance for the technology.
Also Read: Rezolut Partners with Centrelake to Expand Imaging Services in Southern California
“The goal of Leo Cancer Care and McLaren Proton Therapy Center’s collaboration is to bring proton therapy to more patients, and we know there are clear advantages with proton therapy,” said Stephen Towe, CEO, Leo Cancer Care. “The McLaren Proton Therapy Center is well positioned to become the first to potentially treat patients with the revolutionary Leo Cancer Care technology.”
Towe noted research highlighting that upright positioning results in less organ movement during treatment. It also creates better communication channels between the patient and clinician. Proton therapy delivers highly targeted doses of radiation to cancer cells while sparing healthy tissue, reducing side effects, and resulting in successful outcomes. Benefits of delivering radiation therapy to patients seated in an upright position include comfort and a better patient experience compared to laying down on a table.
The McLaren Proton Therapy Center, part of the Karmanos Cancer Institute at McLaren Flint, is already the largest proton center in Michigan. The new Leo Cancer Care technology will increase patient throughput, improving access to proton therapy for patients afflicted with cancer in Michigan and beyond.
“McLaren and Karmanos are committed to delivering world-class, comprehensive cancer care right in Genesee County,” said Chris Candela, president and CEO of McLaren Flint. “The aim of our innovative partnership with Leo Cancer Care is to provide greater access to proton therapy for patients throughout Michigan and around the globe.” The inclusion of the LEO Cancer Care Technology and expansion of the McLarenProton Therapy Center is part of a larger project to grow and improve McLaren Flint’s Comprehensive Cancer Program.